In patients with elevated prostate-specific antigen (PSA) levels, the combination of multiparametric MRI and MR-guided prostate biopsy has higher diagnostic performance for detection of clinically significant prostate cancer (csPC) eligible for curative therapies such as radical prostatectomy are indicated compared with standard systematic prostate biopsy1–4. This evidence concerns the gene KLK3 and Familial prostate cancer.